Table 6.
Variable | Group | Number | Average | STD | Min | Median | Max | p-value |
---|---|---|---|---|---|---|---|---|
Flow ratio tumor/ hind limb (baseline phase) | Control | 14 | 1.37 | 0.69 | 0.42 | 1.43 | 2,49 | 0.54 |
RIC | 14 | 1.20 | 0.63 | 0.47 | 1.02 | 2,56 | ||
sO2 ratio tumor/hind limb (baseline phase) | Control | 14 | 0.85 | 0.29 | 0.39 | 0.81 | 1,57 | 0.35 |
RIC | 14 | 0.92 | 0.27 | 0.42 | 0.89 | 1,50 | ||
rHb ratio tumor/hind limb (baseline phase) | Control | 14 | 0.67 | 0.30 | 0.30 | 0.68 | 1,19 | 0.45 |
RIC | 14 | 0.72 | 0.23 | 0.31 | 0.75 | 0,98 | ||
Flow ratio tumor/ hind limb (last reperfusion phase) | Control | 14 | 1.36 | 0.50 | 0.41 | 1.42 | 2,07 | 0.7 |
RIC | 14 | 1.40 | 0.77 | 0.59 | 1.15 | 2,83 | ||
sO2 ratio tumor/hind limb (last reperfusion phase) | Control | 14 | 0.85 | 0.16 | 0.66 | 0.81 | 1.14 | 0.03* |
RIC | 14 | 1.03 | 0.32 | 0.27 | 0.96 | 1.68 | ||
rHb ratio tumor/hind limb (last reperfusion phase) | Control | 14 | 0.70 | 0.26 | 0.43 | 0.56 | 1.12 | 0.16 |
RIC | 14 | 0.86 | 0.33 | 0.46 | 0.79 | 1.67 | ||
Δ flow hind limb | Control | 14 | 15.53 | 29.84 | -39.42 | 22.92 | 46.72 | 0.11 |
RIC | 14 | -7.17 | 44.96 | -94.03 | 7.30 | 63.19 | ||
Δ flow tumor | Control | 14 | 16.26 | 35.98 | -47.65 | 17.91 | 85.48 | 0.7 |
RIC | 14 | 11.36 | 33.39 | -44.33 | 12.95 | 78.76 | ||
Δ sO2 hind limb | Control | 14 | 6.02 | 9.92 | -9.98 | 4.55 | 22.42 | 0.15 |
RIC | 14 | -2.20 | 13.14 | -36.00 | 2.70 | 10.54 | ||
Δ sO2 tumor | Control | 14 | 5.27 | 8.95 | -6.18 | 1.06 | 23.97 | 0.87 |
RIC | 14 | 3.91 | 8.37 | -6.56 | 3.14 | 22.81 | ||
Δ rHb hind limb | Control | 14 | -1.09 | 6.10 | -17.68 | 0.83 | 6.07 | 0.32 |
RIC | 14 | -9.44 | 16.51 | -45.65 | -1.38 | 5.60 | ||
Δ rHb tumor | Control | 14 | 0.27 | 12.99 | -37.00 | 3.00 | 16.68 | 0.95 |
RIC | 14 | 0.58 | 10.51 | -17.86 | 1.87 | 18.20 |
A statistically significant result is indicated with an asterisk (*).